Total Payments
$9,540
2024 Payments
$2,616
Companies
44
Transactions
409
Medicare Patients
1,799
Medicare Billing
$192,985
Payment Breakdown by Category
Food & Beverage$9,394 (98.5%)
Other$143.12 (1.5%)
Education$3.53 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,394 | 403 | 98.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $143.12 | 1 | 1.5% |
| Education | $3.53 | 1 | 0.0% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$9,540
405 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,699 | 101 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $960.73 | 45 | $0 (2024) |
| Gilead Sciences, Inc. | $741.42 | 32 | $0 (2024) |
| Janssen Biotech, Inc. | $622.56 | 26 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $576.25 | 27 | $0 (2024) |
| PFIZER INC. | $571.65 | 23 | $0 (2024) |
| Celgene Corporation | $285.57 | 18 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $228.18 | 8 | $0 (2024) |
| Organon Llc | $194.63 | 8 | $0 (2024) |
| Novo Nordisk Inc | $179.17 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,616 | 87 | ABBVIE INC. ($962.38) |
| 2023 | $2,279 | 91 | AbbVie Inc. ($624.44) |
| 2022 | $1,585 | 65 | ABBVIE INC. ($425.90) |
| 2021 | $509.38 | 27 | AbbVie Inc. ($102.56) |
| 2020 | $218.69 | 12 | Novo Nordisk Inc ($53.03) |
| 2019 | $853.20 | 42 | AbbVie, Inc. ($296.55) |
| 2018 | $776.11 | 43 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($184.15) |
| 2017 | $702.29 | 42 | AbbVie, Inc. ($109.84) |
All Payment Transactions
409 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $31.35 | General |
| Category: VIROLOGY | ||||||
| 12/22/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/16/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: GI | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.52 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 11/19/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: VIROLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $31.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $33.32 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Rare Disease | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $34.45 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Immunology | ||||||
| 10/04/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/27/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: VIROLOGY | ||||||
| 09/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/24/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.40 | General |
| Category: Neuroscience | ||||||
| 09/16/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: GI | ||||||
| 09/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/10/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $30.20 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $136.46 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 469 | 706 | $238,708 | $56,372 |
| 2022 | 17 | 465 | 821 | $271,624 | $57,059 |
| 2021 | 17 | 460 | 636 | $242,906 | $44,249 |
| 2020 | 15 | 405 | 460 | $192,939 | $35,305 |
Total Patients
1,799
Total Services
2,623
Medicare Billing
$192,985
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 103 | 103 | $78,216 | $15,010 | 19.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 20 | 155 | $17,205 | $6,306 | 36.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 29 | 29 | $24,000 | $6,299 | 26.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 21 | 96 | $15,360 | $5,035 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 70 | $14,711 | $4,504 | 30.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 51 | 52 | $33,840 | $4,154 | 12.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 37 | 37 | $15,244 | $3,757 | 24.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 17 | 17 | $10,384 | $3,098 | 29.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 41 | 64 | $10,048 | $2,550 | 25.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $8,496 | $2,391 | 28.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $6,427 | $2,013 | 31.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 14 | $4,326 | $1,139 | 26.3% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 26 | 26 | $451.00 | $116.75 | 25.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 83 | 83 | $75,198 | $10,334 | 13.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 21 | 234 | $33,228 | $9,632 | 29.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 21 | 134 | $25,058 | $7,254 | 28.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 31 | 31 | $26,040 | $6,388 | 24.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 54 | 55 | $37,235 | $4,285 | 11.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $10,890 | $2,918 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 46 | $12,880 | $2,812 | 21.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 12 | 12 | $6,624 | $2,364 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 20 | $7,900 | $2,182 | 27.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 17 | $6,545 | $1,936 | 29.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $8,625 | $1,899 | 22.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 31 | 47 | $5,170 | $1,460 | 28.2% |
About Dr. Eric Yap, MD
Dr. Eric Yap, MD is a Gastroenterology healthcare provider based in Bellevue, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639254279.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Yap, MD has received a total of $9,540 in payments from pharmaceutical and medical device companies, with $2,616 received in 2024. These payments were reported across 409 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($9,394).
As a Medicare-enrolled provider, Yap has provided services to 1,799 Medicare beneficiaries, totaling 2,623 services with total Medicare billing of $192,985. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Bellevue, WA
- Active Since 10/25/2006
- Last Updated 05/02/2019
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1639254279
Products in Payments
- ENTYVIO (Biological) $676.33
- RINVOQ (Biological) $659.15
- XELJANZ (Drug) $554.82
- STELARA (Biological) $552.94
- XIFAXAN (Drug) $388.44
- Humira (Biological) $378.54
- SKYRIZI (Biological) $360.37
- LINZESS (Drug) $310.55
- MAVYRET (Drug) $299.26
- DUPIXENT (Biological) $291.06
- ZENPEP (Drug) $286.14
- ZEPOSIA (Drug) $285.57
- CREON (Drug) $218.38
- ESD - Core Endoscopy (Device) $143.12
- Phasix Mesh (Device) $125.52
- APRISO (Drug) $120.78
- HUMIRA (Biological) $120.48
- UBRELVY (Drug) $119.85
- VIBERZI (Drug) $118.80
- Entyvio (Biological) $111.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Bellevue
Venkatachala Mohan, Md, MD
Gastroenterology — Payments: $744,268
Gastroenterology $744,268
Shie-Pon Tzung, Md Phd, MD PHD
Gastroenterology — Payments: $39,955
Gastroenterology $39,955
Robert Wohlman, Md, MD
Gastroenterology — Payments: $37,463
Gastroenterology $37,463
Sang Kim, M.d, M.D
Gastroenterology — Payments: $30,884
Gastroenterology $30,884
Raj Butani, M.d, M.D
Gastroenterology — Payments: $12,430
Gastroenterology $12,430
Edwin Lai, M.d, M.D
Gastroenterology — Payments: $11,715
Gastroenterology $11,715